A recent study entitled “Differential intrahepatic integrated HBV DNA patterns between HBeAg-positive and HBeAg-negative chronic hepatitis B,” published in the journal Gut, highlights important new insights into hepatitis B virus (HBV) integration biology. The study demonstrated distinct
[caption id="attachment_20570" align="alignright" width="300"] Sin nombre nantavirus, CDC image enhanced by AI[/caption]Research on hantaviruses has been relatively limited, according to scientists at Baruch S. Blumberg Institute, because these viruses infect a small number of people each year,
Blumberg Institute faculty presented at the HEP-DART 2025, Dec. 7-11, 2025 in Honolulu, Hawaii. HEP-Dart, an in-person meeting, is designed for vibrant scientific presentations and discussion, as well as for new investigators to meet leaders.Yanming Du, professor
Blumberg Institute Distinguished Professor Richard G. Pestell, MD, PhD FACP, FRACP, MBA, gave presentations recently at two international scientific conferences on a promising potential therapy for metastatic triple-negative breast cancer.The new findings presented at European Society for
Richard G. Pestell, AO, MB, BS, PhD, MD, FRACP, Doctorus Honoris Causa, D. MedSci, FACP, FAAAS, FRSB, MBA, FRCP (Ireland), FRC (London), MAE, distinguished professor at the Blumberg Institute was recently elected to membership of the Hungarian National Academy of
Several Blumberg Institute faculty and research staff recently participated in the 38th International Conference on Antiviral Research (ICAR) hosted by the International Society for Antiviral Research (ISAR), in Las Vegas.Dimitar Gotchev, PhD, presented on “an Oral Hepatitis
Four prominent scientists, included one American, Dr. Richard Pestell, have received funding by the Research Hungary (HUN-REN) program for high impact research (read more here).The HUN-REN program’s five-year $2.6 million grant will support Dr. Pestell’s groundbreaking studies to overcome
Two scientists with extensive industrial drug discovery and development experience recently joined the Baruch S. Blumberg Institute faculty as professors of Antiviral Drug Discovery and Development.Andrea Cuconati, PhD, a resident of Upper Dublin Township, and Dimitar Gotchev,
Dr. Fuxuan Wang, a postdoctoral researcher in Dr. Jinhong Chang’s lab at the Blumberg Institute, delivered an oral presentation in the 2024 ASV Meeting. The title of his talk is “A Yellow Fever Virus NS4B Inhibitor sequentially Inhibits Viral
The authors are Blumberg Institute scientists and colleagues at the University of North Carolina. Abstract: Dihydroquinolizinones (DHQs) that inhibit cellular polyadenylating polymerases 5 and 7 (PAPD5 & 7), such as RG7834, have been shown to inhibit both
